Physician

Manuel C. Perry, MD

According to 2025 Medicare claims, Manuel Perry, MD (NPI: 1982691648) practices hematology/oncology in the Kiryas Joel-Poughkeepsie-Newburgh, NY market, with the plurality of this provider's patient population coming from Orange, NY. This provider's primary affiliated billing organization is CRYSTAL RUN HEALTHCARE PHYSICIANS LLP (NPI: 1952376410; TIN: 133843560) and primary practice location at 10941-9998.

Perry's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 742 traditional Medicare patients, billed 82,621 HCPCS/CPT codes, and received $1,865,919 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,925 prescription claims across 287 beneficiaries totaling $4,632,728 in drug costs, led by Promacta (Eltrombopag Olamine). DME data shows 11 claims. Open Payments data shows 7 records totaling $23,349. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $934,285 to $1,865,919. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $662,126 to $4,632,728. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.4M$2.8M2015 Medicare payment: $934,285 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,256,399 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,511,698 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,625,027 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,734,331 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,171,796 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,530,431 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,307,963 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,841,647 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,865,919 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201572582,584$934,285
201671195,485$1,256,399
201763369,247$1,511,698
201862170,614$1,625,027
201966393,351$1,734,331
2020719104,134$2,171,796
2021748113,615$2,530,431
2022757107,876$2,307,963
2023768129,613$2,841,647
202474282,621$1,865,919

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.3M$4.6M2015 Drug cost: $662,126 (USD; Tot_Drug_Cst)2016 Drug cost: $1,278,533 (USD; Tot_Drug_Cst)2017 Drug cost: $930,042 (USD; Tot_Drug_Cst)2018 Drug cost: $1,748,271 (USD; Tot_Drug_Cst)2019 Drug cost: $2,153,182 (USD; Tot_Drug_Cst)2020 Drug cost: $2,853,543 (USD; Tot_Drug_Cst)2021 Drug cost: $2,646,114 (USD; Tot_Drug_Cst)2022 Drug cost: $2,561,343 (USD; Tot_Drug_Cst)2023 Drug cost: $3,521,324 (USD; Tot_Drug_Cst)2024 Drug cost: $4,632,728 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152301,543$662,126
20162171,356$1,278,533
20171961,253$930,042
20182191,405$1,748,271
20192261,553$2,153,182
20202561,568$2,853,543
20212561,432$2,646,114
20222531,408$2,561,343
20232821,763$3,521,324
20242871,925$4,632,728

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$16K$31K2015 Medicare payment: $31,321 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $25,697 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $11,940 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $3,832 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $711 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $9,117 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $619 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R137$31,321
2016N/R39$25,697
2017N/R34$11,940
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/R58$3,832
2022N/R18$711
2023N/R13$9,117
2024N/R11$619

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more344985$101
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more304458$70
80053Blood test, comprehensive group of blood chemicals240779$10
36415Insertion of needle into vein for collection of blood sample4321,465$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count3971,322$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
PromactaEltrombopag Olamine24690$475,073
CalquenceAcalabrutinib Maleate29870$437,977
RevlimidLenalidomide26728$374,188
LenalidomideLenalidomide29812$360,954
IbrancePalbociclib18504$319,814

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J8521Capecitabine, oral, 500 mgNN/R11$618

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.0$0N/R
Research PaymentsReported research-related payment or transfer-of-value amount.7$23,349Sumitomo Pharma America, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Manuel C. Perry, MD?

Tedicare shows public-source Medicare data for Manuel C. Perry, MD (NPI 1982691648), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Manuel C. Perry, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Manuel C. Perry, MD?

Manuel C. Perry, MD is linked to CRYSTAL RUN HEALTHCARE PHYSICIANS LLP (billing NPI 1952376410) in the available physician profile data.

Does Manuel C. Perry, MD have Open Payments data?

Manuel C. Perry, MD has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.